China Biotech Services Holdings Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for China Biotech Services Holdings.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Healthcare earnings growth | 18.6% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
Recent updates
China Biotech Services Holdings Limited's (HKG:8037) 28% Share Price Plunge Could Signal Some Risk
Aug 12
Some Shareholders Feeling Restless Over China Biotech Services Holdings Limited's (HKG:8037) P/S Ratio
Jun 26China Biotech Services Holdings Limited's (HKG:8037) Popularity With Investors Under Threat As Stock Sinks 31%
Mar 07Earnings Not Telling The Story For China Biotech Services Holdings Limited (HKG:8037) After Shares Rise 46%
Jan 18We Think China Biotech Services Holdings (HKG:8037) Might Have The DNA Of A Multi-Bagger
Jan 06Does China Biotech Services Holdings (HKG:8037) Have A Healthy Balance Sheet?
Dec 09These 4 Measures Indicate That China Biotech Services Holdings (HKG:8037) Is Using Debt Safely
Aug 24A Look At The Fair Value Of China Biotech Services Holdings Limited (HKG:8037)
Nov 05Is China Biotech Services Holdings (HKG:8037) A Risky Investment?
Oct 13What China Biotech Services Holdings Limited's (HKG:8037) 35% Share Price Gain Is Not Telling You
Jun 28China Biotech Services Holdings (HKG:8037) Could Become A Multi-Bagger
Mar 16China Biotech Services Holdings (HKG:8037) Knows How To Allocate Capital Effectively
Dec 01Under The Bonnet, China Biotech Services Holdings' (HKG:8037) Returns Look Impressive
Jul 26China Biotech Services Holdings' (HKG:8037) Robust Earnings Are Supported By Other Strong Factors
Apr 05Investors Shouldn't Overlook China Biotech Services Holdings' (HKG:8037) Impressive Returns On Capital
Mar 23Did You Miss China Biotech Services Holdings' (HKG:8037) Whopping 825% Share Price Gain?
Feb 23Chun-Shun Ko Just Bought 27% More Shares In China Biotech Services Holdings Limited (HKG:8037)
Jan 28
What Is The Ownership Structure Like For China Biotech Services Holdings Limited (HKG:8037)?
Jan 11The Trend Of High Returns At China Biotech Services Holdings (HKG:8037) Has Us Very Interested
Dec 08In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as China Biotech Services Holdings has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 6/30/2024 | 62 | -145 | -419 | -211 | N/A |
| 3/31/2024 | 98 | -120 | N/A | N/A | N/A |
| 12/31/2023 | 212 | -95 | 132 | 195 | N/A |
| 9/30/2023 | 776 | 33 | N/A | N/A | N/A |
| 6/30/2023 | 1,347 | 159 | 513 | 610 | N/A |
| 3/31/2023 | 1,598 | 208 | N/A | N/A | N/A |
| 12/31/2022 | 1,852 | 258 | 375 | 483 | N/A |
| 9/30/2022 | 1,394 | 74 | N/A | N/A | N/A |
| 6/30/2022 | 937 | 3 | 222 | 257 | N/A |
| 3/31/2022 | 854 | 53 | N/A | N/A | N/A |
| 12/31/2021 | 624 | 19 | 28 | 41 | N/A |
| 9/30/2021 | 614 | 113 | N/A | N/A | N/A |
| 6/30/2021 | 999 | 155 | 296 | 426 | N/A |
| 3/31/2021 | 797 | 54 | N/A | N/A | N/A |
| 12/31/2020 | 656 | 30 | 295 | 422 | N/A |
| 9/30/2020 | 564 | -21 | N/A | N/A | N/A |
| 6/30/2020 | 62 | -105 | -57 | -50 | N/A |
| 3/31/2020 | 58 | -106 | N/A | N/A | N/A |
| 12/31/2019 | 59 | -99 | -38 | -30 | N/A |
| 9/30/2019 | 62 | -76 | N/A | N/A | N/A |
| 6/30/2019 | 65 | -72 | -38 | -34 | N/A |
| 3/31/2019 | 67 | -66 | N/A | N/A | N/A |
| 12/31/2018 | 70 | -64 | -21 | -15 | N/A |
| 9/30/2018 | 75 | -95 | N/A | N/A | N/A |
| 6/30/2018 | 79 | -83 | -45 | -40 | N/A |
| 3/31/2018 | 88 | -48 | N/A | N/A | N/A |
| 12/31/2017 | 105 | -63 | N/A | -57 | N/A |
| 9/30/2017 | 111 | -48 | N/A | N/A | N/A |
| 6/30/2017 | 113 | -64 | N/A | -11 | N/A |
| 3/31/2017 | 104 | -103 | N/A | N/A | N/A |
| 12/31/2016 | 87 | -86 | N/A | -25 | N/A |
| 9/30/2016 | 69 | -81 | N/A | N/A | N/A |
| 6/30/2016 | 52 | -84 | N/A | -90 | N/A |
| 3/31/2016 | 39 | -72 | N/A | N/A | N/A |
| 12/31/2015 | 34 | -54 | N/A | -85 | N/A |
| 9/30/2015 | 3 | -36 | N/A | N/A | N/A |
| 6/30/2015 | 38 | -21 | N/A | -19 | N/A |
| 3/31/2015 | 56 | -43 | N/A | N/A | N/A |
| 12/31/2014 | 70 | -75 | N/A | -40 | N/A |
| 9/30/2014 | 111 | -85 | N/A | N/A | N/A |
| 6/30/2014 | 92 | -84 | N/A | -78 | N/A |
| 3/31/2014 | 89 | -79 | N/A | N/A | N/A |
| 12/31/2013 | 85 | -60 | N/A | -42 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 8037's forecast earnings growth is above the savings rate (2.3%).
Earnings vs Market: Insufficient data to determine if 8037's earnings are forecast to grow faster than the Hong Kong market
High Growth Earnings: Insufficient data to determine if 8037's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if 8037's revenue is forecast to grow faster than the Hong Kong market.
High Growth Revenue: Insufficient data to determine if 8037's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 8037's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/26 14:54 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
China Biotech Services Holdings Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|